Cargando…
Serum BDNF as a Potential Biomarker of Alzheimer's Disease: Verification Through Assessment of Serum, Cerebrospinal Fluid, and Medial Temporal Lobe Atrophy
There is an urgent need to establish blood biomarkers for Alzheimer's disease (AD). Although it has been speculated that brain-derived neurotrophic factor (BDNF) is associated with AD, whether it can be used as a blood biomarker has yet to be determined. We used serum, cerebrospinal fluid (CSF)...
Autores principales: | Mori, Yukiko, Tsuji, Mayumi, Oguchi, Tatsunori, Kasuga, Kensaku, Kimura, Atsushi, Futamura, Akinori, Sugimoto, Azusa, Kasai, Hideyo, Kuroda, Takeshi, Yano, Satoshi, Hieda, Sotaro, Kiuchi, Yuji, Ikeuchi, Takeshi, Ono, Kenjiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102980/ https://www.ncbi.nlm.nih.gov/pubmed/33967943 http://dx.doi.org/10.3389/fneur.2021.653267 |
Ejemplares similares
-
Sex Differences in the Relationship of Serum Vitamin B1 and B12 to Dementia Among Memory Clinic Outpatients in Japan
por: Miki, Ayako, et al.
Publicado: (2021) -
Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer’s disease
por: Hara, Norikazu, et al.
Publicado: (2017) -
Cerebral white matter lesions and regional blood flow are associated with reduced cognitive function in early-stage cognitive impairment
por: Kuroda, Takeshi, et al.
Publicado: (2023) -
High serum high-density lipoprotein-cholesterol is associated with memory function and gyrification of insular and frontal opercular cortex in an elderly memory-clinic population
por: Kinno, Ryuta, et al.
Publicado: (2019) -
α-Synuclein as CSF and Blood Biomarker of Dementia with Lewy Bodies
por: Kasuga, Kensaku, et al.
Publicado: (2012)